| PERIOD ENDING | 31-Jan-09 | 31-Jan-08 | 31-Jan-07 | | Total Revenue | 16,286 | 16,563 | 15,867 | | Cost of Revenue | 8,865 | 8,086 | 7,167 | | | Gross Profit | 7,421 | 8,477 | 8,700 | | | Operating Expenses | | Research Development | 2,264 | 3,133 | 2,716 | | Selling General and Administrative | 6,503 | 6,048 | 5,803 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (1,347) | (704) | 182 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 8 | 6 | 77 | | Earnings Before Interest And Taxes | (1,339) | (698) | 259 | | Interest Expense | 24 | 26 | 131 | | Income Before Tax | (1,363) | (724) | 128 | | Income Tax Expense | 12 | 11 | 31 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,375) | (736) | 96 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (1,375) | (736) | 96 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,375) | ($736) | $96 |
|
0.01% Nasdaq 
0.22%
Income Statement
